Supporting this, several studies have reported that treatment with TNF-α-inhibitors in Crohn’s disease patients could potentially lead to the onset of anti-NMDAR encephalitis (MacKay and Salh, 2024; Noble and Lancaster, 2018; Oh et al., 2022). This evidence concerns the gene TNF and viral encephalitis.